Cargando…
Tongguan capsule for treating myocardial ischemia-reperfusion injury: integrating network pharmacology and mechanism study
CONTEXT: Although Tongguan capsule (TGC) is used in the treatment of coronary atherosclerotic disease, the exact mechanism remains unclear. OBJECTIVE: Network pharmacology and experimental validation were applied to examine the mechanism of TGC for treating myocardial ischemia-reperfusion injury (MI...
Autores principales: | Liu, Jiantao, Liu, Chunping, Chen, Huiqi, Cen, Huan, Yang, Hailong, Liu, Peijian, Liu, Fang, Ma, Liuling, Chen, Quanfu, Wang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937005/ https://www.ncbi.nlm.nih.gov/pubmed/36789620 http://dx.doi.org/10.1080/13880209.2023.2175877 |
Ejemplares similares
-
Tongguan Capsule Protects against Myocardial Ischemia and Reperfusion Injury in Mice
por: Qi, Jianyong, et al.
Publicado: (2013) -
Tongguan capsule ameliorates coronary artery stenosis in a 40-year-old woman
por: Ma, Huan, et al.
Publicado: (2015) -
Tongguan Capsule Mitigates Post-myocardial Infarction Remodeling by Promoting Autophagy and Inhibiting Apoptosis: Role of Sirt1
por: Mao, Shuai, et al.
Publicado: (2018) -
Shuangshen Ningxin capsule alleviates myocardial ischemia–reperfusion injury in miniature pigs by modulating mitophagy: network pharmacology and experiments in vivo
por: Jia, Feifan, et al.
Publicado: (2023) -
Tongguan capsule‐derived herb reduces susceptibility to atrial fibrillation by inhibiting left atrial fibrosis via modulating cardiac fibroblasts
por: Ma, Shiyu, et al.
Publicado: (2018)